Emergent BioSolutions EBS
NYSE EBS
$6.07 -0.03 (-0.49%)
As of: Nov 10, 2026 · 1:01 PM EST

Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026)

Updated

Analysis

Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 7.68 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 11.12 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 11.14 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.61 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 9.70 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 4.84 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 7.09 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn 147.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 147.30 Mn
Jun 30, 2026 359.40 Mn
Mar 31, 2026 145.60 Mn
Dec 31, 2025 176.60 Mn
Sep 30, 2025 154.60 Mn
Jun 30, 2025 139.30 Mn
Mar 31, 2025 172.30 Mn
Dec 31, 2024 204.20 Mn
Sep 30, 2024 229.30 Mn
Jun 30, 2024 458.20 Mn
Mar 31, 2024 260.60 Mn
Dec 31, 2023 320.40 Mn
Sep 30, 2023 512.60 Mn
Jun 30, 2023 630.80 Mn
Mar 31, 2023 311.90 Mn
Dec 31, 2022 385.50 Mn
Sep 30, 2022 285.20 Mn
Jun 30, 2022 314.70 Mn
Mar 31, 2022 301.10 Mn
Dec 31, 2021 437.90 Mn
API Access

Emergent BioSolutions Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY